Testing effectiveness (Phase 2)Study completedNCT00831974What this trial is testingEfficacy of AB1010 in Patients With Systemic Indolent MastocytosisWho this might be right forMastocytosis AB Science 23
Testing effectiveness (Phase 2)Study completedNCT00416624What this trial is testingEpoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by ChemotherapyWho this might be right forAnemiaLeukemiaLymphoma+4 more Mayo Clinic 239
Very early researchStudy completedNCT00424242What this trial is testingPemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Northwestern University 15
Testing effectiveness (Phase 2)Study completedNCT00186628What this trial is testingPhase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHDWho this might be right forLeukemia, Mast-CellMantle-cell Lymphoma Stanford University 36
Not applicableAvailableNCT06915766What this trial is testingExpanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic MastocytosisWho this might be right forSystemic Mastocytoses, IndolentSystemic Mastocytoses, Aggressive Cogent Biosciences, Inc.
Not applicableNo Longer AvailableNCT05219266What this trial is testingManaged Access Programs for PKC412, MidostaurinWho this might be right forFMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid LeukemiaAcute Myeloid LeukemiaAggressive Systemic Mastocytosis+2 more Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00666211What this trial is testingOpioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Vanderbilt-Ingram Cancer Center 98
Not applicableStudy completedNCT00897767What this trial is testingCollecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical TrialWho this might be right forLeukemiaLymphoma Eastern Cooperative Oncology Group 1,873
Large-scale testing (Phase 3)Looking for participantsNCT04910685What this trial is testing(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic MastocytosisWho this might be right forIndolent Systemic MastocytosisSmoldering Systemic Mastocytosis Blueprint Medicines Corporation 534
Not applicableLooking for participantsNCT07255638What this trial is testingA Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in GermanyWho this might be right forIndolent Systemic Mastocytosis Blueprint Medicines Corporation 80
Testing effectiveness (Phase 2)Study completedNCT01807598What this trial is testingBrentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell LeukemiaWho this might be right forAggressive Systemic MastocytosisMast Cell LeukemiaSystemic Mastocytosis Jason Robert Gotlib 10
Large-scale testing (Phase 3)Study completedNCT00750009What this trial is testingPersonalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Case Comprehensive Cancer Center 583
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Not applicableStudy completedNCT03632811What this trial is testingAdaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French LanguageWho this might be right forCutaneous MastocytosisIndolent Systemic Mastocytosis University Hospital, Toulouse 30
Large-scale testing (Phase 3)Study completedNCT00814073What this trial is testingMasitinib in Severe Indolent or Smoldering Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis AB Science 135
Testing effectiveness (Phase 2)Study completedNCT01273766What this trial is testingDeferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesWho this might be right forAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more Wake Forest University Health Sciences 16
Not applicableWithdrawnNCT00900120What this trial is testingCollecting and Storing Blood Samples From Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more University of Medicine and Dentistry of New Jersey
Not applicableStudy completedNCT01334996What this trial is testingUse of Tamoxifen in Systemic MastocytosisWho this might be right forSystemic Mastocytosis Mayo Clinic 1
Early research (Phase 1)Study completedNCT02571036What this trial is testingA Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced MalignanciesWho this might be right forGastrointestinal Stromal TumorsAdvanced Systemic MastocytosisAdvanced Cancers Deciphera Pharmaceuticals, LLC 282
Not applicableUnknownNCT05923372What this trial is testingEvaluation of the DALY on a Cohort of Patients With Indolent Systemic MastocytosisWho this might be right forMastocytosis, Indolent Systemic University Hospital, Toulouse 160